Sign in

XERI on OTC

XERIANT, INC.

XERIANT, INC. is an aircraft company, listed on OTC (XERI).1 It is headquartered in Boca Raton, Florida.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$392.3KNet income, fiscal 20262

Compare with Archer Aviation, DUKE Robotics Corp. or SDR Drone, Inc., or pick any stock.

  • TickerXERI on OTC1
  • IndustryAircraft1
  • HeadquartersBoca Raton, Florida1
  • Business addressInnovation Centre #1, 3998 Fau Blvd., Suite 309, Boca Raton, Fl 334313
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Xeriant, Inc. (the “Company) is dedicated to the discovery, development, and commercialization of transformative technologies, with a focus on advanced materials that can be successfully integrated and deployed across multiple industrial sectors. Xeriant’s advanced materials line is marketed under the DUREVER™ brand and includes NexBoard™, a high-performance eco-friendly composite construction panel made from recycled plastic and fiber waste, and NexPatch™, its companion fire-resistant joint compound. Both products use the Company’s proprietary fire-retardant technology, called Durazite™. NexBoard™ has shown exceptional resistance to fire, water, mold, insects, cracking, abrasion, compression and puncture, and was designed to become a universal panel to replace products such as drywall, plywood, OSB, MDF, MgO board, cement board and other materials used in construction. Durazite also has…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

-$794.8KFree cash flow2

Financial statements

Operating income56789102-$1.1M in 2026+457% since 2019
-$15.0M-$10.0M-$5.0M02019: -$190.0K-$190.0K20192020: -$362.7K-$362.7K2020+91%2021: -$2.2M-$2.2M2021+506%2022: -$11.0M-$11.0M2022+401%2023: -$2.1M-$2.1M2023−81%2024: -$1.9M-$1.9M2024−7%2025: -$1.4M-$1.4M2025−28%2026: -$1.1M-$1.1M2026−23%
Net income56789102$392.3K in 2026
-$15.0M-$10.0M-$5.0M0$5.0M2019: -$4.4M-$4.4M20192020: -$699.6K-$699.6K2020−84%2021: -$2.7M-$2.7M2021+286%2022: -$13.3M-$13.3M2022+392%2023: -$7.1M-$7.1M2023−47%2024: -$3.1M-$3.1M2024−56%2025: -$1.6M-$1.6M2025−47%2026: $392.3K$392.3K2026

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2026-06-302025-06-30
Consulting and advisory fees$293.5K$328.0K
Related party consulting fees$296.0K$438.0K
General and administrative expenses$185.3K$309.1K
Professional fees$183.5K$221.1K
Research and development expense$99.9K$69.3K
Total operating expenses$1.1M$1.4M
Loss from operations-$1.1M-$1.4M
Amortization of debt discount-$214.2K-$51.0K
Interest expense-$68.5K-$225.6K
Loss on extinguishment of debt-$1.1M-$4.8K
Gain on extinguishment of debt$2.8M$0
Total other income (expense), net$1.5M-$281.4K
Net income (loss) before income tax expense$408.2K-$1.6M
Income tax expense-$15.9K$0
Net income (loss)$392.3K-$1.6M
Less net loss attributable to noncontrolling interest$0-$17.2K
Net income (loss) attributable to common stockholders$392.3K-$1.6M
Basic$0.00$0.00
Diluted$0.00$0.00
Basic867.8M shares620.9M shares
Diluted1.7B shares620.9M shares

Compare XERIANT, INC. with another company

What it owns

What XERIANT, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$5.1K2 Jun 30, 2026$4.2K2 Jun 30, 2025+23.8%
Operating-lease assets (leased space)$3.1K2 Jun 30, 2026$7.4K2 Jun 30, 2025−57.9%

Real estate and locations

ItemLatestA year beforeChange
Area of land2,911 sq ft10 Jun 30, 2025

Properties, in its own words

The Company’s headquarters consists of leased office space located in the Research Park at Florida Atlantic University, 3651 FAU Blvd., Suite 400, Boca Raton, FL 33431.

Item 2 of the 10-K filed Sep 28, 2026.4

Leadership

Who has led XERIANT, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Bradley W. Miller2011
  2. Brendan Macpherson2013–2014

President

  1. Randy S. Bayne2012
201520202025
Board members and other officers (7)

Former names

  • Banjo & Matilda, Inc.Nov 13, 2013 to Sep 29, 20203
  • EASTERN WORLD SOLUTIONS, INC.Nov 16, 2012 to Oct 1, 20133
  • Encom Group, Inc.Apr 5, 2012 to Nov 15, 20123
  • Eastern World Solutions Inc.Jan 25, 2010 to Apr 20, 20123

Timeline

  1. Nov 12, 20258-K Entered a material agreement; Unregistered sale of shares22
  2. Apr 2, 20258-K Executive or director change23
  3. Jan 23, 20258-K Other events24
  4. Aug 5, 20248-K Change of auditor25
  5. Dec 12, 20238-K Other events26
  6. Oct 6, 20238-K Change of auditor27
  7. Aug 31, 20238-K Change of auditor28
  8. Dec 30, 20228-K Entered a material agreement; Unregistered sale of shares29
  9. Aug 3, 20228-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure30
  10. Apr 4, 20228-K Entered a material agreement; Unregistered sale of shares; Other events31
  11. Nov 4, 20218-K Entered a material agreement; New debt or obligation; Unregistered sale of shares32
  12. Dec 24, 2013New chief executive Brendan Macpherson becomes CEO15
  13. Feb 17, 2011New chief executive Bradley W. Miller becomes CEO16

Filings

48 filings to the SEC since October 2021: 7 annual reports, 16 quarterly reports, 11 major events, 1 insider forms, 13 other. The latest 20:

  1. Sep 28, 202610-K EDGAR
  2. May 15, 202610-Q EDGAR
  3. Feb 17, 202610-Q EDGAR
  4. Nov 19, 202510-Q EDGAR
  5. Nov 14, 2025NT 10-Q EDGAR
  6. Nov 12, 20258-K EDGAR
  7. Oct 2, 202510-K EDGAR
  8. Sep 29, 2025NT 10-K EDGAR
  9. May 15, 202510-Q EDGAR
  10. Apr 2, 20258-K EDGAR
  11. Feb 14, 202510-Q EDGAR
  12. Jan 23, 20258-K EDGAR
  13. Nov 14, 202410-Q EDGAR
  14. Oct 8, 202410-K EDGAR
  15. Sep 30, 2024NT 10-K EDGAR
  16. Aug 5, 20248-K EDGAR
  17. May 14, 202410-Q EDGAR
  18. Mar 8, 2024SEC STAFF ACTION EDGAR
  19. Feb 14, 202410-Q EDGAR
  20. Dec 12, 20238-K EDGAR

The 48 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 0 buys and 7 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 24, 2022DeFeudis Edward C.DirectorSale75,000$0.12$9.0KForm 4
Mar 23, 2022DeFeudis Edward C.DirectorSale41,871$0.12$5.0KForm 4
Mar 22, 2022DeFeudis Edward C.DirectorSale50,000$0.12$6.0KForm 4
Mar 18, 2022DeFeudis Edward C.DirectorSale15,000$0.12$1.8KForm 4
Mar 15, 2022DeFeudis Edward C.DirectorSale75,000$0.12$9.0KForm 4
Mar 14, 2022DeFeudis Edward C.DirectorSale60,000$0.12$7.2KForm 4
Mar 10, 2022DeFeudis Edward C.DirectorSale15,999$0.12$1.9KForm 4

From Forms 4 filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Williams Jones Wealth Management, LLC.150,288$2.1K0.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How XERIANT, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARXERIANT, INC.1
  • CIK0001481504
  • Employer ID (EIN)27-15191784
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
  • Incorporated inFlorida4
  • Fiscal year endsJune 301
  • Industry code (SIC)3721 Aircraft1
  • SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance1
  • Business addressInnovation Centre #1, 3998 Fau Blvd., Suite 309, Boca Raton, FL 334311
  • Phone561-491-95951
  • Shares outstanding1,086,360,294 shares as of Sep 25, 20264
  • Public float$11.6M as of Dec 31, 20254
  • AuditorAstra Audit & Advisory LLC, Tampa, Florida PCAOB ID 6920; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceJan 25, 20101
  • Filings183 in all: 10-Q (50), 8-K (35), 10-K (16), NT 10-Q (16), NT 10-K (9), UPLOAD (9), 3 (8), 10-Q/A (5)1
    All 27 form types

    S-1/A (5), 8-K/A (4), CORRESP (4), 4 (3), DEF 14C (2), PRE 14C (2), S-1 (2), SC 13D (2), 10-K/A (1), 15-12G (1), 424B3 (1), 8-A12G (1), EFFECT (1), RW WD (1), S-8 (1), S-8 POS (1), SC 13G (1), SC 14F1 (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Sep 28, 2026
    Quarterly report (10-Q) May 15, 2026
    Latest 8-K (8-K) Nov 12, 2025

Risk factors and legal proceedings

The risks XERIANT, INC. names in Item 1A of its 10-K filed Sep 28, 2026: 45 risks under these headings, as written.4

  • RISKS RELATING TO OUR FINANCIAL POSITION AND CAPITAL NEEDS
  • We are in our development stage and have a limited operating history.
  • We anticipate operating losses to continue into the foreseeable future and substantial additional capital may be required that may not be available on acceptable terms.
  • The high capital requirements of building materials manufacturing may require us to seek large-scale financing, including potential green bond financing or similar structured debt instruments, that may not be available on terms acceptable to us or at all.
  • We will need to resolve the obligations required by the Auctus Fund LLC Senior Secured Note.
  • Not obtaining sufficient financing will jeopardize our operations and the ability to execute our business plan.
  • Our recurring operating losses have raised substantial doubt regarding our ability to continue as a going concern.
  • RISKS RELATING TO OUR BUSINESS OPERATIONS
  • Our business is substantially concentrated in the building materials industry, and adverse conditions in that industry could materially harm our results of operations.
  • Widespread acceptance of NexBoard™ as a replacement for conventional building materials may be slow, uncertain, and more costly than anticipated due to established procurement relationships and resistance to change.
  • The manufacture of NexBoard™ at commercial scale requires substantial capital investment that we may be unable to raise on acceptable terms or at all.
  • Our reliance on contract manufacturing introduces risks of quality control, production capacity, delivery reliability, and confidentiality that are outside of our direct control.
The other 35 risks
  • We face pricing pressure from established, well-capitalized competitors in the construction materials market who benefit from economies of scale, entrenched distribution networks, and lower per-unit production costs.
  • Our products may be subject to building code approval processes, certification requirements, and regulatory compliance obligations that could delay or restrict commercialization.
  • Our operations and products may be subject to environmental, health, and safety regulations that could increase our costs or restrict our operations.
  • If we are unable to effectively manage our growth, our ability to implement our business strategy and our operating results will likely be materially adversely affected.
  • We are dependent on key personnel.
  • Operations could be adversely affected by interruptions from suppliers of components that are beyond our control.
  • Changes in the economy could have a detrimental impact on the Company.
  • Our business, results of operations and financial condition may be adversely impacted by pandemics or other significant public health conditions.
  • Our success is dependent upon our keeping pace with the advances in technology.
  • We could face liability or disruption from security breaches.
  • Litigation may adversely affect our business, financial condition, and results of operations.
  • Our insurance coverage may be inadequate to cover all significant risk exposures.
  • RISKS RELATED TO OUR DEPENDENCE ON THIRD PARTIES
  • We may fail to retain or recruit necessary personnel, and we may be unable to secure the services of consultants.
  • We may be subject to claims that our consultants or independent contractors have wrongfully used or disclosed alleged trade secrets of their other clients or former employers to us.
  • RISKS RELATED TO OUR INTELLECTUAL PROPERTY
  • Unauthorized disclosure or reverse engineering of our proprietary fire-retardant formulation could materially compromise our competitive position, even if patent protection is in place.
  • Third parties may challenge the validity or enforceability of U.S. Patent No. 12,679,047, and an adverse outcome could materially harm our competitive position and commercial prospects.
  • If competitors develop products that design around our patents or independently achieve comparable performance characteristics, our competitive advantages may be diminished.
  • We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights, as well as costs associated with lawsuits.
  • We cannot be certain we will be able to obtain patent protection to protect our product candidates and technology.
  • We may infringe the intellectual property rights of others, which may prevent or delay our product development efforts and stop us from commercializing or increase the costs of commercializing our product candidates.
  • We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed alleged trade secrets.
  • If we are not able to protect and control our unpatented trade secrets, know-how and other technological innovation, we may suffer competitive harm.
  • RISKS RELATED TO OWNING OUR COMMON STOCK
  • We do not intend to pay cash dividends on our common stock in the foreseeable future.
  • If we are unable to establish appropriate internal financial reporting controls and procedures, it could cause us to fail to meet our reporting obligations, result in the restatement of our financial statements, harm our operating results, subject us to regulatory scrutiny and sanction, cause investors to lose confidence in our reported financial information and have a negative effect on the market price for shares of our Common Stock.
  • The price of our common stock may be volatile and fluctuate substantially.
  • Our directors and executive officers can exert significant control over our business and affairs and have actual or potential interests that may depart from those of investors in the subsequent financings.
  • We may issue more shares in a future financing or pursuant to existing agreements which will result in substantial dilution.
  • Our Board of Directors is authorized to issue Preferred Stock without obtaining shareholder approval.
  • An active trading market for our common stock may not develop, and you may not be able to sell your common stock.
  • Market and economic conditions may negatively impact our business, financial condition and share price.
  • Future sales and issuances of our common stock could result in additional dilution of the percentage ownership of our stockholders and could cause our share price to fall.
  • We may be at risk of securities class action litigation.
  • Our Amended and Restated Articles of Incorporation and our Amended and Restated Bylaws, and Nevada law may have anti-takeover effects that could discourage, delay or prevent a change in control, which may cause our stock price to decline.
  • Financial reporting obligations of being a public company in the U.S. are expensive and time-consuming, and our management will be required to devote substantial time to compliance matters.
  • There will be a substantial number of common shares eligible for future sale from the conversion of Series A Preferred shares.

Legal proceedings

Effective October 29, 2025, Xeriant terminated its previously disclosed litigation proceedings with Auctus Fund, LLC and entered into a Settlement Agreement with Auctus to restructure the Auctus Note and related obligations. A summary of the terms of the Settlement Agreement is discussed on the Liquidity and Capital Resources section below. Xeriant is currently working on securing funding to fulfill its obligations under the Settlement Agreement and has ongoing discussions with Auctus regarding extending the cash payments based on the Company’s timelines in executing its business plan, particularly certification testing of NEXBOARD. The Company’s ongoing lawsuit against XTI Aircraft Company has a connection to the Auctus matter in that the Company’s obligations to Auctus were, according to Xeriant’s complaint, to be assumed by XTI as provided in a Letter Agreement. Separately, Auctus Fund, LLC sued XTI related to the Letter Agreement.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
    SEC EDGAROther events
  25. 25
  26. 26
    SEC EDGAROther events
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32